➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Last Updated: August 13, 2020

DrugPatentWatch Database Preview

GARDASIL Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Tradename: GARDASIL

Patents:	9
Applicants:	2
BLAs:	2
Suppliers: see list	2
Recent Clinical Trials:	See clinical trials for GARDASIL

Recent Clinical Trials for GARDASIL

Identify potential brand extensions & biosimilar entrants

Sponsor	Phase
Boston Medical Center	Phase 4
Merck Sharp & Dohme Corp.	Phase 3
Alessandro Ghelardi	Phase 3

See all GARDASIL clinical trials

Patent Text Search: US Patents for GARDASIL

These patents were identified by searching patent claims

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
A-s Medication Solutions	GARDASIL	human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant	INJECTION, SUSPENSION	125126	001	2006-06-08	Start Trial	SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL)	2033-03-11			search
A-s Medication Solutions	GARDASIL	human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant	INJECTION, SUSPENSION	125126	001	2006-06-08	Start Trial	Evrys Bio, LLC (Doylestown, PA)	2040-02-29			search
A-s Medication Solutions	GARDASIL	human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant	INJECTION, SUSPENSION	125126	001	2006-06-08	Start Trial	Marbley; Theodore C. (Palm Springs, CA)	2035-07-21			search
A-s Medication Solutions	GARDASIL	human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant	INJECTION, SUSPENSION	125126	001	2006-06-08	Start Trial	SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL)	2029-05-13			search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patents for GARDASIL

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Canada	2818814	Start Trial
Australia	2013203892	Start Trial
Hungary	E032563	Start Trial
Taiwan	201531484	Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson

McKinsey

Boehringer Ingelheim

Dow

Express Scripts

AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.